With the theme "Global Leadership in Pooling Wisdom: Enabling Chinese Pharmaceuticals," the conference centered on the latest guidance documents from ISPE and facilitated multidimensional academic exchanges. These exchanges covered biopharmaceutical production, cell and gene therapy, chemical production and risk management, engineering design and project management, manufacturing engineering, pharmaceutical administration regulations, pharmaceutical engineering supply chains, innovation transformation and investment, as well as digitalization and AI. The event invited leaders from drug regulatory authorities, experts from domestic and international academic institutions, and industry representatives to conduct policy and regulation promulgations, technical exchanges, and experience sharing.

The aim was to establish a platform for communication between upstream and downstream enterprises and industry experts across China's entire pharmaceutical engineering industry chain, promoting cross-border cooperation among production, education, research, and medicine, and opening up the full pharmaceutical engineering industry chain. This initiative seeks to facilitate better, faster, and higher-quality development of China's pharmaceutical manufacturing industry.